Pharmex-K8
Natural health product licensed in Canada
- Other names
- Pharmex K600, Pharmex-K600
- Licence holder
- Propharmex Inc.
- NPN or DIN-HM
- 80088787
- Status
- Active licence
- Licence date
- 17 October 2018
- Revision date
- 23 April 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 3,720 mg a day according to the dosing instructions published by Health Canada (12 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Potassium Source : Chlorure de potassium | 310 mg | 3,720,000 µg |
| Potassium Source : Chlorure de potassium | 8 mEq | Not calculated |
Non-medicinal ingredients
Talc, Acide stéarique, Poly(éthylène glycol), Éthylcellulose, Dioxyde de silicium colloïdal, Dioxyde de titane, Poly(alcool vinylique), Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Comprimé ; maximum: 3 Comprimé | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Treatment or prevention of hypokalemia which does not result from dietary deficiency. Potassium replacement therapy. Electrolyte replenisher.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
A probable association exists between the use of coated tablets containing potassium salts with or without thiazide diuretics and the incidence of serious small bowel ulceration. Such preparations should be used only when adequate dietary supplementation is not practical and should be discontinued if abdominal pain, distention, nausea, vomiting or gastrointestinal bleeding occur. Consult a health care practitioners prior to use if you have diabetes, or a kidney or cardiovascular disorder. Consult a Health care practitioner prior to use if you are pregnant or breastfeeding.
- Contre-indications
Do not use with other potassium containing supplements, with potassium containing salt substitutes, sparing diuretics, angiotensin converting enzyme ACE inhibitors (Spironolactone, triamterene, amiloride} or are taking prescription medications. Do not use if you have gastrointestinal ulceration or obstruction. Do not use if you have trouble swallowing (dysphagia} or if you are at a high risk for potassium chloride induced gastric lesions (e.g. due to recent gastric surgery} Not to be used following vigorous exercise or acute dehydration (unless administered with an appropriate balance of other mineral salts, e.g. sodium}
Source
Official Health Canada record, licence 80088787
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging